Literature DB >> 9736027

Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor.

A K Stalder1, M J Carson, A Pagenstecher, V C Asensio, C Kincaid, M Benedict, H C Powell, E Masliah, I L Campbell.   

Abstract

To examine the role of tumor necrosis factor (TNF)-alpha in the pathogenesis of degenerative disorders of the central nervous system (CNS), transgenic mice were developed in which expression of murine TNF-alpha was targeted to astrocytes using a glial fibrillary acidic protein (GFAP)-TNF-alpha fusion gene. In two independent GFAP-TNFalpha transgenic lines (termed GT-8 or GT-2) adult (>4 months of age) animals developed a progressive ataxia (GT-8) or total paralysis affecting the lower body (GT-2). Symptomatic mice had prominent meningoencephalitis (GT-8) or encephalomyelitis (GT-2) in which large numbers of B cells and CD4+ and CD8+ T cells accumulated at predominantly perivascular sites. The majority of these lymphocytes displayed a memory cell phenotype (CD44high, CD62Llow, CD25-) and expressed an early activation marker (CD69). Parenchymal lesions contained mostly CD45+ high, MHC class II+, and Mac-1+ cells of the macrophage microglial lineage with lower numbers of neutrophils and few CD4+ and CD8+ T cells. Cerebral expression of the cellular adhesion molecules ICAM-1, VCAM-1, and MAdCAM as well as a number of alpha- and beta-chemokines was induced or upregulated and preceded the development of inflammation, suggesting an important signaling role for these molecules in the CNS leukocyte migration. Degenerative changes in the CNS of the GFAP-TNFalpha mice paralleled the development of the inflammatory lesions and included primary and secondary demyelination and neurodegeneration. Disease exacerbation with more extensive inflammatory lesions that contained activated cells of the macrophage/microglial lineage occurred in GFAP-TNFalpha mice with severe combined immune deficiency. Thus, persistent astrocyte expression of murine TNF-alpha in the CNS induces a late-onset chronic inflammatory encephalopathy in which macrophage/microglial cells but not lymphocytes play a central role in mediating injury.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9736027      PMCID: PMC1852999          DOI: 10.1016/S0002-9440(10)65620-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  78 in total

1.  Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta.

Authors:  I Y Chung; E N Benveniste
Journal:  J Immunol       Date:  1990-04-15       Impact factor: 5.422

2.  Mature microglia resemble immature antigen-presenting cells.

Authors:  M J Carson; C R Reilly; J G Sutcliffe; D Lo
Journal:  Glia       Date:  1998-01       Impact factor: 7.452

Review 3.  Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis.

Authors:  E N Benveniste
Journal:  J Mol Med (Berl)       Date:  1997-03       Impact factor: 4.599

4.  Tumor necrosis factor alpha and transforming growth factor beta upregulate astrocyte expression of monocyte chemoattractant protein-1.

Authors:  A A Hurwitz; W D Lyman; J W Berman
Journal:  J Neuroimmunol       Date:  1995-03       Impact factor: 3.478

5.  Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia.

Authors:  S L Wesselingh; C Power; J D Glass; W R Tyor; J C McArthur; J M Farber; J W Griffin; D E Griffin
Journal:  Ann Neurol       Date:  1993-06       Impact factor: 10.422

6.  Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared.

Authors:  A L Ford; A L Goodsall; W F Hickey; J D Sedgwick
Journal:  J Immunol       Date:  1995-05-01       Impact factor: 5.422

7.  The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis.

Authors:  N Sommer; P A Löschmann; G H Northoff; M Weller; A Steinbrecher; J P Steinbach; R Lichtenfels; R Meyermann; A Riethmüller; A Fontana
Journal:  Nat Med       Date:  1995-03       Impact factor: 53.440

8.  Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections.

Authors:  I Garcia; Y Miyazaki; K Araki; M Araki; R Lucas; G E Grau; G Milon; Y Belkaid; C Montixi; W Lesslauer
Journal:  Eur J Immunol       Date:  1995-08       Impact factor: 5.532

9.  Simultaneous analysis of multiple cytokine receptor mRNAs by RNase protection assay in LPS-induced endotoxemia.

Authors:  A K Stalder; I L Campbell
Journal:  Lymphokine Cytokine Res       Date:  1994-04

10.  Expression of a tumor necrosis factor alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes.

Authors:  Y Higuchi; P Herrera; P Muniesa; J Huarte; D Belin; P Ohashi; P Aichele; L Orci; J D Vassalli; P Vassalli
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  28 in total

1.  CNS-derived CCL21 is both sufficient to drive homeostatic CD4+ T cell proliferation and necessary for efficient CD4+ T cell migration into the CNS parenchyma following Toxoplasma gondii infection.

Authors:  Corinne C Ploix; Shahani Noor; Janelle Crane; Kokoechat Masek; Whitney Carter; David D Lo; Emma H Wilson; Monica J Carson
Journal:  Brain Behav Immun       Date:  2010-09-22       Impact factor: 7.217

Review 2.  CNS immune privilege: hiding in plain sight.

Authors:  Monica J Carson; Jonathan M Doose; Benoit Melchior; Christoph D Schmid; Corinne C Ploix
Journal:  Immunol Rev       Date:  2006-10       Impact factor: 12.988

3.  Regulation of glucagon secretion by glucose transporter type 2 (glut2) and astrocyte-dependent glucose sensors.

Authors:  Nell Marty; Michel Dallaporta; Marc Foretz; Martine Emery; David Tarussio; Isabelle Bady; Christophe Binnert; Friedrich Beermann; Bernard Thorens
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

4.  Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease.

Authors:  R Lee Mosley; Eric J Benner; Irena Kadiu; Mark Thomas; Michael D Boska; Khader Hasan; Chad Laurie; Howard E Gendelman
Journal:  Clin Neurosci Res       Date:  2006-12-06

5.  The cellular response in neuroinflammation: The role of leukocytes, microglia and astrocytes in neuronal death and survival.

Authors:  Monica J Carson; J Cameron Thrash; Barbara Walter
Journal:  Clin Neurosci Res       Date:  2006-12

6.  Astrocytes promote TNF-mediated toxicity to oligodendrocyte precursors.

Authors:  Sunja Kim; Andrew J Steelman; Hisami Koito; Jianrong Li
Journal:  J Neurochem       Date:  2010-12-02       Impact factor: 5.372

7.  IFNgamma enhances microglial reactions to hippocampal axonal degeneration.

Authors:  M B Jensen; I V Hegelund; N D Lomholt; B Finsen; T Owens
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

Review 8.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

Review 9.  Transgenic models for cytokine-induced neurological disease.

Authors:  Iain L Campbell; Markus J Hofer; Axel Pagenstecher
Journal:  Biochim Biophys Acta       Date:  2009-10-14

10.  Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease.

Authors:  Benoit Melchior; Angie E Garcia; Bor-Kai Hsiung; Katherine M Lo; Jonathan M Doose; J Cameron Thrash; Anna K Stalder; Matthias Staufenbiel; Harald Neumann; Monica J Carson
Journal:  ASN Neuro       Date:  2010-07-12       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.